This report aims to provide a comprehensive presentation of the global market for Biosimulation, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimulation.
The Biosimulation market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biosimulation market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimulation manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global Biosimulation market size in 2022 is 2490.56 million US dollars, and it is expected to be 6945.95 million US dollars by 2029, with a compound annual growth rate of 15.78% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Biosimulation market include Inosim Software, Nuventra Pharma, Insilico Biotechnology, Leadinvent Technologies, and In Silico Biosciences. The share of the top 3 players in the Biosimulation market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of Biosimulation market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Software accounted for XX% of Biosimulation market in 2022. Services share of XX%.
Pharmaceutical and Biotechnology Companies accounted for XX% of the Biosimulation market in 2022. Research Institutes accounts for XX%.
Highlights-Regions
Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey
Player list
Inosim Software
Nuventra Pharma
Insilico Biotechnology
Leadinvent Technologies
In Silico Biosciences
Evidera
Physiomics
Genedata
Rosa
Chemical Computing Group
Advanced Chemistry Development
Schrödinger
Dassault Systèmes
Simulation Plus
Certara
Physiomics
Rhenovia Pharma Ltd
Entelos, Inc.
Leadscope Inc
Acceryls Inc.
Types list
Software
Services
Application list
Pharmaceutical and Biotechnology Companies
Research Institutes
Contract Research Organizations
Regulatory Authorities
Other End Users
Table of Content
1 Study Coverage
1.1 Biosimulation Product Introduction
1.2 Market by Type
1.2.1 Global Biosimulation Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Biosimulation Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Biosimulation Market by Region
1.4.1 Global Biosimulation Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Biosimulation Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Biosimulation Revenue by Players
2.1.1 Global Biosimulation Revenue by Players (2018-2023)
2.1.2 Global Biosimulation Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Biosimulation Revenue in 2023
2.2 Global Biosimulation Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Biosimulation Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Inosim Software
3.1.1 Inosim Software Information
3.1.2 Inosim Software Overview
3.1.3 Inosim Software Biosimulation Revenue and Gross Margin (2018-2023)
3.1.4 Inosim Software Related Developments
3.2 Nuventra Pharma
3.2.1 Nuventra Pharma Information
3.2.2 Nuventra Pharma Overview
3.2.3 Nuventra Pharma Biosimulation Revenue and Gross Margin (2018-2023)
3.2.4 Nuventra Pharma Related Developments
3.3 Insilico Biotechnology
3.3.1 Insilico Biotechnology Information
3.3.2 Insilico Biotechnology Overview
3.3.3 Insilico Biotechnology Biosimulation Revenue and Gross Margin (2018-2023)
3.3.4 Insilico Biotechnology Related Developments
3.4 Leadinvent Technologies
3.4.1 Leadinvent Technologies Information
3.4.2 Leadinvent Technologies Overview
3.4.3 Leadinvent Technologies Biosimulation Revenue and Gross Margin (2018-2023)
3.4.4 Leadinvent Technologies Related Developments
3.5 In Silico Biosciences
3.5.1 In Silico Biosciences Information
3.5.2 In Silico Biosciences Overview
3.5.3 In Silico Biosciences Biosimulation Revenue and Gross Margin (2018-2023)
3.5.4 In Silico Biosciences Related Developments
3.6 Evidera
3.6.1 Evidera Information
3.6.2 Evidera Overview
3.6.3 Evidera Biosimulation Revenue and Gross Margin (2018-2023)
3.6.4 Evidera Related Developments
3.7 Physiomics
3.7.1 Physiomics Information
3.7.2 Physiomics Overview
3.7.3 Physiomics Biosimulation Revenue and Gross Margin (2018-2023)
3.7.4 Physiomics Related Developments
3.8 Genedata
3.8.1 Genedata Information
3.8.2 Genedata Overview
3.8.3 Genedata Biosimulation Revenue and Gross Margin (2018-2023)
3.8.4 Genedata Related Developments
3.9 Rosa
3.9.1 Rosa Information
3.9.2 Rosa Overview
3.9.3 Rosa Biosimulation Revenue and Gross Margin (2018-2023)
3.9.4 Rosa Related Developments
3.10 Chemical Computing Group
3.10.1 Chemical Computing Group Information
3.10.2 Chemical Computing Group Overview
3.10.3 Chemical Computing Group Biosimulation Revenue and Gross Margin (2018-2023)
3.10.4 Chemical Computing Group Related Developments
3.11 Advanced Chemistry Development
3.11.1 Advanced Chemistry Development Information
3.11.2 Advanced Chemistry Development Overview
3.11.3 Advanced Chemistry Development Biosimulation Revenue and Gross Margin (2018-2023)
3.11.4 Advanced Chemistry Development Related Developments
3.12 Schrödinger
3.12.1 Schrödinger Information
3.12.2 Schrödinger Overview
3.12.3 Schrödinger Biosimulation Revenue and Gross Margin (2018-2023)
3.12.4 Schrödinger Related Developments
3.13 Dassault Systèmes
3.13.1 Dassault Systèmes Information
3.13.2 Dassault Systèmes Overview
3.13.3 Dassault Systèmes Biosimulation Revenue and Gross Margin (2018-2023)
3.13.4 Dassault Systèmes Related Developments
3.14 Simulation Plus
3.14.1 Simulation Plus Information
3.14.2 Simulation Plus Overview
3.14.3 Simulation Plus Biosimulation Revenue and Gross Margin (2018-2023)
3.14.4 Simulation Plus Related Developments
3.15 Certara
3.15.1 Certara Information
3.15.2 Certara Overview
3.15.3 Certara Biosimulation Revenue and Gross Margin (2018-2023)
3.15.4 Certara Related Developments
3.16 Physiomics
3.16.1 Physiomics Information
3.16.2 Physiomics Overview
3.16.3 Physiomics Biosimulation Revenue and Gross Margin (2018-2023)
3.16.4 Physiomics Related Developments
3.17 Rhenovia Pharma Ltd
3.17.1 Rhenovia Pharma Ltd Information
3.17.2 Rhenovia Pharma Ltd Overview
3.17.3 Rhenovia Pharma Ltd Biosimulation Revenue and Gross Margin (2018-2023)
3.17.4 Rhenovia Pharma Ltd Related Developments
3.18 Entelos, Inc.
3.18.1 Entelos, Inc. Information
3.18.2 Entelos, Inc. Overview
3.18.3 Entelos, Inc. Biosimulation Revenue and Gross Margin (2018-2023)
3.18.4 Entelos, Inc. Related Developments
3.19 Leadscope Inc
3.19.1 Leadscope Inc Information
3.19.2 Leadscope Inc Overview
3.19.3 Leadscope Inc Biosimulation Revenue and Gross Margin (2018-2023)
3.19.4 Leadscope Inc Related Developments
3.20 Acceryls Inc.
3.20.1 Acceryls Inc. Information
3.20.2 Acceryls Inc. Overview
3.20.3 Acceryls Inc. Biosimulation Revenue and Gross Margin (2018-2023)
3.20.4 Acceryls Inc. Related Developments
4 Market Size by Type
4.1 Global Biosimulation Revenue by Type
4.2 Global Biosimulation Market Size Growth by Type 2018-2023
5 Market Size by Application
5.1 Global Biosimulation Revenue by Application
5.2 Global Biosimulation Market Size Growth by Application 2018-2023
6 Global Biosimulation Market Insights
6.1 Global Biosimulation Market Revenue 2018-2023
6.2 Global Biosimulation Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Biosimulation Market Size by Country
7.1.1 Americas Biosimulation Revenue by Country (2018-2023)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Biosimulation Market Size by Country
8.1.1 Europe Biosimulation Revenue by Country (2018-2023)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Biosimulation Market Size by Region
9.1.1 Asia Pacific Biosimulation Revenue by Region (2018-2023)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Biosimulation Market Size by Country
10.1.1 Middle East and Africa Biosimulation Revenue by Country (2018-2023)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Biosimulation Industry Trends
11.2 Biosimulation Market Drivers
11.3 Biosimulation Market Challenges
11.4 Biosimulation Market Restraints
12 Biosimulation Forecasted Market Size by Type
12.1 Global Biosimulation Forecasted Revenue by Type
12.2 Global Biosimulation Forecasted Market Size Growth by Type 2023-2029
13 Biosimulation Forecasted Market Size by Application
13.1 Global Biosimulation Forecasted Revenue by Application
13.2 Global Biosimulation Forecasted Market Size Growth by Application 2023-2029
14 Global Biosimulation Market Forecasts
14.1 Global Biosimulation Market Revenue Forecasts 2023-2029
14.2 Global Biosimulation Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer
List of Tables and Figures
Figure Biosimulation Picture
Table Product Definition of Biosimulation
Table Global Biosimulation Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
Table Global Biosimulation Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
Table Global Biosimulation Market by Region: 2018 VS 2023 VS 2029
Figure Global Biosimulation Revenue Market Size & Forecasts 2018-2029
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Biosimulation Revenue by Players (2018-2023)
Table Global Biosimulation Revenue Market Share by Players (2018-2023)
Figure Top 5 Largest Players of Biosimulation in 2023
Figure Top 10 Largest Players of Biosimulation in 2023
Table Global Biosimulation Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Biosimulation Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Inosim Software Overview
Table Inosim Software Revenue, Gross, Gross Margin 2018-2023
Table Inosim Software Related Developments
Table Company Profiles
Table Nuventra Pharma Overview
Table Nuventra Pharma Revenue, Gross, Gross Margin 2018-2023
Table Nuventra Pharma Related Developments
Table Company Profiles
Table Insilico Biotechnology Overview
Table Insilico Biotechnology Revenue, Gross, Gross Margin 2018-2023
Table Insilico Biotechnology Related Developments
Table Company Profiles
Table Leadinvent Technologies Overview
Table Leadinvent Technologies Revenue, Gross, Gross Margin 2018-2023
Table Leadinvent Technologies Related Developments
Table Company Profiles
Table In Silico Biosciences Overview
Table In Silico Biosciences Revenue, Gross, Gross Margin 2018-2023
Table In Silico Biosciences Related Developments
Table Company Profiles
Table Evidera Overview
Table Evidera Revenue, Gross, Gross Margin 2018-2023
Table Evidera Related Developments
Table Company Profiles
Table Physiomics Overview
Table Physiomics Revenue, Gross, Gross Margin 2018-2023
Table Physiomics Related Developments
Table Company Profiles
Table Genedata Overview
Table Genedata Revenue, Gross, Gross Margin 2018-2023
Table Genedata Related Developments
Table Company Profiles
Table Rosa Overview
Table Rosa Revenue, Gross, Gross Margin 2018-2023
Table Rosa Related Developments
Table Company Profiles
Table Chemical Computing Group Overview
Table Chemical Computing Group Revenue, Gross, Gross Margin 2018-2023
Table Chemical Computing Group Related Developments
Table Company Profiles
Table Advanced Chemistry Development Overview
Table Advanced Chemistry Development Revenue, Gross, Gross Margin 2018-2023
Table Advanced Chemistry Development Related Developments
Table Company Profiles
Table Schrödinger Overview
Table Schrödinger Revenue, Gross, Gross Margin 2018-2023
Table Schrödinger Related Developments
Table Company Profiles
Table Dassault Systèmes Overview
Table Dassault Systèmes Revenue, Gross, Gross Margin 2018-2023
Table Dassault Systèmes Related Developments
Table Company Profiles
Table Simulation Plus Overview
Table Simulation Plus Revenue, Gross, Gross Margin 2018-2023
Table Simulation Plus Related Developments
Table Company Profiles
Table Certara Overview
Table Certara Revenue, Gross, Gross Margin 2018-2023
Table Certara Related Developments
Table Company Profiles
Table Physiomics Overview
Table Physiomics Revenue, Gross, Gross Margin 2018-2023
Table Physiomics Related Developments
Table Company Profiles
Table Rhenovia Pharma Ltd Overview
Table Rhenovia Pharma Ltd Revenue, Gross, Gross Margin 2018-2023
Table Rhenovia Pharma Ltd Related Developments
Table Company Profiles
Table Entelos, Inc. Overview
Table Entelos, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Entelos, Inc. Related Developments
Table Company Profiles
Table Leadscope Inc Overview
Table Leadscope Inc Revenue, Gross, Gross Margin 2018-2023
Table Leadscope Inc Related Developments
Table Company Profiles
Table Acceryls Inc. Overview
Table Acceryls Inc. Revenue, Gross, Gross Margin 2018-2023
Table Acceryls Inc. Related Developments
Table Global Biosimulation Revenue by Type (2018-2023)
Table Global Biosimulation Revenue Share by Type (2018-2023)
Table Global Biosimulation Revenue by Application (2018-2023)
Table Global Biosimulation Revenue Share by Application (2018-2023)
Figure Global Biosimulation Market Revenue 2018-2023
Table Global Biosimulation Revenue by Region (2018-2023)
Table Global Biosimulation Revenue Share by Region (2018-2023)
Figure Americas Biosimulation Revenue (2018-2023)
Figure Europe Biosimulation Revenue (2018-2023)
Figure Asia-Pacific Biosimulation Revenue (2018-2023)
Figure Middle East & Africa Biosimulation Revenue (2018-2023)
Table Americas Biosimulation Revenue by Country (2018-2023)
Table Americas Biosimulation Revenue Share by Country (2018-2023)
Figure United States Biosimulation Revenue Market Size (2018-2023)
Figure Canada Biosimulation Revenue Market Size (2018-2023)
Figure Mexico Biosimulation Revenue Market Size (2018-2023)
Figure Brazil Biosimulation Revenue Market Size (2018-2023)
Figure Argentina Biosimulation Revenue Market Size (2018-2023)
Table Europe Biosimulation Revenue by Country (2018-2023)
Table Europe Biosimulation Revenue Share by Country (2018-2023)
Figure Germany Biosimulation Revenue Market Size (2018-2023)
Figure France Biosimulation Revenue Market Size (2018-2023)
Figure U.K. Biosimulation Revenue Market Size (2018-2023)
Figure Italy Biosimulation Revenue Market Size (2018-2023)
Figure Russia Biosimulation Revenue Market Size (2018-2023)
Table Asia Pacific Biosimulation Revenue by Region (2018-2023)
Table Asia Pacific Biosimulation Revenue Share by Region (2018-2023)
Figure China Biosimulation Revenue Market Size (2018-2023)
Figure Japan Biosimulation Revenue Market Size (2018-2023)
Figure South Korea Biosimulation Revenue Market Size (2018-2023)
Figure India Biosimulation Revenue Market Size (2018-2023)
Figure Southeast Asia Biosimulation Revenue Market Size (2018-2023)
Figure Australia Biosimulation Revenue Market Size (2018-2023)
Table Middle East and Africa Biosimulation Revenue by Country (2018-2023)
Table Middle East and Africa Biosimulation Revenue Share by Country (2018-2023)
Figure Turkey Biosimulation Revenue Market Size (2018-2023)
Figure Saudi Arabia Biosimulation Revenue Market Size (2018-2023)
Figure U.A.E Biosimulation Revenue Market Size (2018-2023)
Table Global Biosimulation Forecasted Revenue by Type (2018-2023)
Table Global Biosimulation Forecasted Revenue Share by Type (2018-2023)
Table Global Biosimulation Forecasted Revenue by Application (2018-2023)
Table Global Biosimulation Forecasted Revenue Share by Application (2018-2023)
Figure Global Biosimulation Market Revenue Forecasts 2023-2029
Table Global Biosimulation Forecasts Revenue by Region (2023-2029)
Table Global Biosimulation Forecasts Revenue Share by Region (2023-2029)
Figure Americas Biosimulation Forecasts Revenue and Growth (2023-2029)
Figure Europe Biosimulation Forecasts Revenue and Growth (2023-2029)
Figure Asia-Pacific Biosimulation Forecasts Revenue and Growth (2023-2029)
Figure Middle East & Africa Biosimulation Forecasts Revenue and Growth (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
